DISCLOSURES
Data availability statement: The study data is available upon request.
Funding Sources statement: This research was supported by a grant from Medtronic Japan.
Conflict of interest disclosure : This study was financially supported by Medtronic Japan. Dr. Satoshi Higa is a consultant to Japan Life Line and Johnson & Johnson and received ’ ’speaker’s honoraria from Japan Life Line, Medtronic, Abbott, Bayer, Biotronik, Boehringer-Ingelheim, Bristol-Myers, Daiichi-Sankyo Pharmaceutical Company, and Pfizer.
Ethics approval statement: The study protocol was approved by the institutional review board of each participating center.
Patient consent statement: Written informed consent was obtained from the patients for obtaining the data.
Permission to reproduce material from other sources: N/A
Clinical trial registration : N/A
Address for correspondence: Yasushi Oginosawa MD, PhD.
The Second Department of Internal Medicine, University of Occupational and Environment Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyusyu 807-8556, Japan
Tel.: +81-93-691-7250, Fax: +93-691-6913
E-mail: y-ogi@med.uoeh-u.ac.jp
ORCID: http://orcid.org/0000-0002-0955-7791